This webinar will be hosted live and available on-demand
Wednesday, April 8, 2026
11:00 AM - 3:30 PM ET
New approach methodologies (NAMs) can generate human-relevant data that complements traditional approaches. As such, in vitro NAM technologies, such as organoids, organ-on-a-chip systems, and other in vitro human tissue models, are being increasingly used to gain human-relevant insights throughout drug discovery processes. These systems offer insights into biological processes and therapeutic interactions, giving scientists a stronger base of evidence to guide decision-making.
In this half-day virtual summit, brought to you by STEMCELL Technologies, invited scientists and industry professionals will discuss the real-world impact and evolving landscape of in vitro NAMs, including the scientific, regulatory, and operational factors shaping the future of NAM-enabled drug discovery.
Agenda
11:00 AM – Opening Remarks
Jenna Moccia
11:05 AM – The ISSCR Consortium on Advanced Stem Cell-Based Models in Drug Discovery & Development
Daniela Cornacchia
11:20 AM – Considerations and Challenges for Adoption of NAMs in Regulatory Toxicology
Clive Roper
12:05 PM – OrganoReady®: Turnkey Organoid and Organ-on-a-Chip Solutions For Broad Adoption and Routine Screening
Paul Vulto
12:30 PM – De-risking Human Organoids for Drug Discovery and Development
Magdalena Kasendra
12:50 PM – BREAK
1:00 PM – Our Next Gen Preclinical Journey: Embracing NAMs
Ludovico Buti
1:25 PM – Integration of Manual and Automated Organoid Workflows Supporting Scalable Culture and High-Throughput Assay Screening Platforms
Sandra Grund-Groschke and Giusy Tornillo
1:50 PM – Gastrointestinal Organoid Systems: Complex In Vitro Models for Drug Toxicity Testing
Riya Sharma
2:15 PM – Roundtable
All speakers
 | Paul Vulto, PhD |
 | Ludovico Buti, PhD |
 | Magdalena Kasendra, PhD |
 | Daniela Cornacchia, PhD |
 | Riya Sharma |
 | Giusy Tornillo, MSc, PhD |
 | Sandra Grund-Gröschke, PhD |
 | Clive Roper, PhD |
 | Jenna Moccia, PhD |
